Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis
Latest Information Update: 17 Mar 2022
At a glance
- Drugs Adalimumab (Primary) ; Antipsoriatics
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms Complete-PS
- Sponsors Abbott Laboratories; AbbVie
- 14 Mar 2022 Results compare real-world effectiveness of adalimumab versus topical/traditional systemic agents for management of moderate to severe plaque psoriasis, published in the Dermatology and Therapy
- 11 Jul 2018 Status changed from active, no longer recruiting to completed.
- 17 Jun 2016 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.